Report Viewer

NINDS CDE Notice of Copyright
Qualiveen
Availability
For more information on this instrument, please visit Qualiveen
 
The Qualiveen short-form can be ordered here: https://eprovide.mapi-trust.org/instruments/qualiveen-short-form and Information for the Qualiveen-30 can be found here: https://eprovide.mapi-trust.org/.
Classification
Supplemental-Highly-Recommended: Spinal Cord Injury (SCI)*
 
*Recommendation on Use: Indicated for studies targeted at evaluating the impact of urinary dysfunction, management and symptoms on one's feelings, fears and concerns.
Short Description of Instrument
A disease-specific quality of life (QoL) measure for individuals with spinal cord injury (SCI) who have urinary disorders.
 
Contains 4 domains:
 
  1. Limitations/Inconvenience (items 1-9)
  2. Constraints/Restrictions (items 10-17)
  3. Fears (items 18-25)
  4. Feelings/Impact on Daily Life (items 26-30)
 
Rationale/Justification
Strengths/Weaknesses: The Qualiveen has been used in both the Multiple Sclerosis (MS) and Spinal Cord Injury (SCI) populations. There is considerable evidence supporting its validity in SCI (Costa et al, 2001, Bonniaud et al, 2008). Additional evidence examining its responsiveness is warranted.
Scoring
Response options are framed as 5-point Likert-type scales, and scores on each item range from 0 (no impact) to 4 (high adverse impact). Each domain score is computed as an average of the scores for the items it contains. Individual items are equally weighted. An overall QoL score also can be calculated from the mean of the 4 domains, with lower scores indicating better QoL (i.e., no limitations constraints, or negative feelings).
References
Key reference:
Costa P, Perrouin-Verbe B, Colvez A, Didier J, Marquis P, Marrel A, Amarenco G, Espirac B, Leriche A. Quality of life in spinal cord injury patients with urinary difficulties. Development and validation of qualiveen. Eur Urol. 2001;39(1):107-113.
 
Additional references:
Best KL, Ethans K, Craven BC, Noreau L, Hitzig SL. Identifying and classifying quality of life tools for neurogenic bladder function after spinal cord injury: A systematic review. J Spinal Cord Med. 2017;40(5):505-529.
 
Bonniaud V, Bryant D, Parratte B, Guyatt G. Qualiveen, a urinary-disorder specific instrument: 0.5 corresponds to the minimal important difference. J Clin Epidemiol. 2008;61(5):505-510.
 
Bonniaud V, Bryant D, Parratte B, Guyatt G. Development and validation of the short form of a urinary quality of life questionnaire: SF-Qualiveen. J Urol. 2008;180(6):2592-2598.
 
Bonniaud V, Bryant D, Parratte B, Gallien P, Guyatt G. Qualiveen: a urinary disorder-specific instrument for use in clinical trials in multiple sclerosis. Arch Phys Med Rehabil. 2006;87(12):1661-1663.
 
Bonniaud V, Bryant D, Pilati C, Menarini M, Lamartina M, Guyatt G, Del Popolo G. Italian version of Qualiveen-30: cultural adaptation of a neurogenic urinary disorder-specific instrument. Neurourol Urodyn. 2011;30(3):354-359.
 
Nikfallah A, Rezaali S, Mohammadi N, et al. Translation, Cultural Adaptation and Validation of the Qualiveen-30 Questionnaire in Persian for Patients with Spinal Cord Injury and Multiple Sclerosis. Low Urin Tract Symptoms. 2015;7(1):42-49.
 
Pannek J, Kullik B. Does optimizing bladder management equal optimizing quality of life? Correlation between health-related quality of life and urodynamic parameters in patients with spinal cord lesions. Urology. 2009;74(2):263-266.
 
Vastenholt JM, Snoek GJ, Buschman HP, van der Aa HE, Alleman ER, Ijzerman MJ. 7-year follow-up of sacral anterior root stimulation for bladder control in patients with a spinal cord injury: quality of life and users' experiences. Spinal Cord. 2003;41(7):397-402.